Pioneering drug for rare eye cancer gets go-ahead to be offered on NHS
Nice approval for Kimmtrak to treat uveal melanoma patients in England is welcomed by campaigners. The drug boosts survival chances for those with this rare eye cancer, offering new hope and valuable time with loved ones.